Page breadcrumb nav

VAERS Report 2157288

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Male

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: fd7959


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2021-06-26
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

bowel blood for 6 months; fatigue for 3 months.; sleepiness; headache after both doses; headache after both doses; inappropriate schedule of vaccine administered; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority-web. the reporter is the patient. regulatory number: it-minisal02-842230. a 43 year-old male patient received bnt162b2 (comirnaty), intramuscular, administration date 26jun2021 (lot number: fd7959) as dose 2, single for covid-19 immunisation. relevant medical history included: "vasculitis" (unspecified if ongoing); "vasculitis" (unspecified if ongoing); "hemochromatosis" (unspecified if ongoing). the patient's concomitant medications were not reported. vaccination history included: comirnaty (1st dose, batch/ lot number: fa5831), administration date: 15may2021, for covid-19 immunisation, reaction(s): "tiredness", "sleepiness", "bloody discharge", "pain", "angina pectoris". the following information was reported: bloody discharge (medically significant) with onset 30jun2021, outcome "not recovered", described as "bowel blood for 6 months"; fatigue (non-serious) with onset 30jun2021, outcome "not recovered", described as "fatigue for 3 months."; somnolence (non-serious) with onset 30jun2021, outcome "not recovered", described as "sleepiness"; pain (non-serious) with onset 30jun2021, outcome "not recovered", headache (non-serious) with onset 30jun2021, outcome "unknown" and all described as "headache after both doses"; inappropriate schedule of product administration (non-serious) with onset 26jun2021, outcome "unknown", described as "inappropriate schedule of vaccine administered". the clinical course of events was as follows: actions taken (the gut softer oily and i saw blood) - impact on quality of life (7/10). event as reported: bowel blood for 6 months - drowsiness. headache after both doses ... pfitzer vaccine. i had severe angina pectoris 1 week after the first dose. fatigue for 3 months. reporter comment: vasculitis and hemochromatosis follow-up attempts are completed. no further information is expected.; reporter's comments: vasculitis and hemochromatosis; sender's comments: linked report(s) : it-pfizer inc-202200324661 1st/ 2nd dose

Données de laboratoire
na
Liste des symptômes
fatigue headache pain somnolence inappropriate schedule of product administration bloody discharge
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na